Using Simplified Meal Boluses Versus Carbohydrate Counting in Adolescents With Hybrid Closed Loop Systems
1 other identifier
interventional
40
1 country
1
Brief Summary
The goal of this trial is to evaluate blood sugar control in patients with type 1 diabetes when using a simple meal bolus strategy (small, medium, large meals) compared to carbohydrate counting when on a hybrid closed loop system. The main question it aims to answer are: What is the blood sugar time in range when using simple meal boluses versus carbohydrate counting? Participants will: Use the simple meal bolus plan for 4 weeks. Do precise carbohydrate counting for 4 weeks. Provide their continuous glucose monitor and pump data Take surveys about the experience of meal bolusing during the study
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 23, 2024
CompletedFirst Posted
Study publicly available on registry
August 28, 2024
CompletedStudy Start
First participant enrolled
November 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2025
CompletedDecember 10, 2024
December 1, 2024
10 months
August 23, 2024
December 5, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Time in Range
% of time sensor glucose values are between 70-180 mg/dL
Measured during the duration of the study period, up to 12 weeks
Secondary Outcomes (3)
Hypoglycemia
Measured during the duration of the study period, up to 12 weeks
Hyperglycemia
Measured during the duration of the study period, up to 12 weeks
Feasibility, acceptability, and self-reported mealtime insulin bolus burden
Given 3 times during the duration of the study period, up to 12 weeks
Study Arms (2)
Simple Meal Bolusing
EXPERIMENTALParticipants will be instructed to enter a set number of carbohydrates before meals based on if they are having a small, medium, or large meal. The preset numbers for meals will be based on their average total daily dose (TDD) determined during the 2-week usual care observation period. The participants will have their insulin to carbohydrate ratios set based on the standard formula of 450/TDD for all meals initially (e.g. a child with a TDD of 50 u/day would have 450/50=9 so an I:C of 1:9). They enter a carbohydrate amount of 30 g for small meals, 60 g for regular meals, and 90 g for large meals.
Precise Carbohydrate counting
ACTIVE COMPARATORParticipants will be instructed to enter a precise carbohydrate count before meals to the best of their ability. Pump settings may be adjusted per provider discretion and typical clinical care during this time period.
Interventions
Participants will enter pre-determined numbers for small, medium, or large carbohydrate meals rather than using precise carbohydrate counting
Participants will be instructed to enter accurate carbohydrate counts to the best of their ability for all meals and snacks
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of T1D of at least 1 year duration
- Using a commercial HCL system
- Willingness to not start any new non-insulin glucose-lowering agent during trial
- Willingness to participate in all study procedures
- Investigator has confidence that participant can successfully operate all study devices and adhere to protocol
You may not qualify if:
- History of \>1 severe hypoglycemic event with seizure or loss of consciousness in the last 6 months or \>1 DKA event in the last 6 months not related to illness or infusion set failure
- History of chronic renal disease or currently on hemodialysis, adrenal insufficiency, hypothyroidism that is not adequately treated, use of oral or injectable steroids within the last 8 weeks, or known ongoing adhesive intolerance
- A condition, which in the opinion of the investigator or designee, would put the participant or study at risk
- Participation in another interventional trial at the time of enrollment
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Barbara Davis Center
Aurora, Colorado, 80045, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 23, 2024
First Posted
August 28, 2024
Study Start
November 25, 2024
Primary Completion
September 30, 2025
Study Completion
September 30, 2025
Last Updated
December 10, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share